There is a newer version of this Section
2022
2021
2020 (you are here)
2019
2018
Other previous versions
View our newest version here

2020 Kentucky Revised Statutes
Chapter 217 - Foods, drugs, and poisons
217.5403 Eligibility requirements for treatment with investigational drug, biological product, or device.

Universal Citation: KY Rev Stat § 217.5403 (2020)
Previous Next

Download as PDF
217.5403 Eligibility requirements for treatment with investigational drug, biological product, or device. A patient shall be eligible for treatment with an investigational drug, biological product, or device if the patient has: (1) A terminal illness that is attested to by the patient's treating health care provider; (2) Considered all other treatment options currently approved by the United States Food and Drug Administration; (3) Received a recommendation from the patient's treating health care provider for an investigational drug, biological product, or device; (4) Given written informed consent for the use of the investigational drug, biological product, or device; and (5) Documentation from the treating health care provider that the patient meets the requirements of this section. Effective: June 29, 2017 History: Created 2017 Ky. Acts ch. 65, sec. 3, effective June 29, 2017. Formerly codified as KRS 217.5405.
Previous Next
Disclaimer: These codes may not be the most recent version. Kentucky may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.